ArticleThe Journal of biological chemistry2019

Novel MASP-2 inhibitors developed via directed evolution of human TFPI1 are potent lectin pathway inhibitors.

Dávid Szakács et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.